Genome-wide association studies (GWAS) have identified many genes that are associated with the development of certain autoimmune disorders, but the major histocompatibility complex (MHC) haplotypes still represent the most prevalent… Click to show full abstract
Genome-wide association studies (GWAS) have identified many genes that are associated with the development of certain autoimmune disorders, but the major histocompatibility complex (MHC) haplotypes still represent the most prevalent genetic risk factor for many autoimmune diseases. The mechanisms by which MHC-associated genetic susceptibility translates into B cell autoimmunity and the development of autoimmune diseases are complex. There is increasing evidence that the MHC haplotype modulates autoreactive B cell responses in multiple ways. Instead of merely inhibiting the production of IgG autoantibodies and mediating complete immunological tolerance, the non-permitting MHC haplotypes seem to facilitate production of IgG autoantibodies exhibiting Fc glycosylation patterns that are associated with reduced pathogenicity and a protective cytokine profile of T follicular helper (Tfh) cells. Here, we discuss mechanisms linking MHC haplotypes to the production of pathogenic IgG autoantibodies, which could be relevant for the development of improved diagnosis, particularly in the context of individual medicine. This article is protected by copyright. All rights reserved.
               
Click one of the above tabs to view related content.